Candida spp. bloodstream infection: influence of antifungal treatment on outcome.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/jac/dkp495PMID 20083551
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

  2009cited by this paper
• Anidulafungin versus fluconazole for invasive candidiasis.

  2007cited by this paper
• The Echinocandins

  2007cited by this paper
• Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial.

  2007cited by this paper
• Differential Time to Positivity: A Useful Method for Diagnosing Catheter-Related Bloodstream Infections

  2004cited by this paper
• Biology and Ecology

  2004cited by this paper
• Comparison of caspofungin and amphotericin B for invasive candidiasis.

  2002cited by this paper
• New tools in diagnosing catheter-related infections

  2000cited by this paper
• A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia

  1994cited by this paper
• A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.

  1994cited by this paper
• Gram-negative bacteremia: IV. Re-evaluation of clinical features and treatment in 612 patients

  1980cited by this paper
• Septic Shock

  1970cited by this paper
• Gram-negative bacteremia.

  1969cited by this paper
• SEPTIC SHOCK

  1964cited by this paper
• Gram-Negative Bacteremia: I. Etiology and Ecology

  1962cited by this paper

• Menthol-based Novel Ultra-Deformable Vesicle: Formulation, Optimization and Evaluation of an Antifungal Drug

  2025cites this paper
• Candidemia Surveillance and Impact on Non-neutropenic Critically Ill Patients

  2024cites this paper
• The impact of implementing an antifungal stewardship with monitoring of 1‐3, β‐D‐glucan values on antifungal consumption and clinical outcomes

  2019cites this paper
• A Literature Review on the Imidazole

  2019cites this paper
• Resistance to the Plant Defensin NaD1 Features Modifications to the Cell Wall and Osmo-Regulation Pathways of Yeast

  2018cites this paper
• [Current therapeutic options in invasive mycosis and potential therapeutic role of isavuconazole].

  2018cites this paper
• Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents

  2018cites this paper
• Antifungal Drug Susceptibility of Candida Species Isolated from HIV-Positive Patients Recruited at a Public Hospital in São Luís, Maranhão, Brazil

  2017cites this paper
• Initial antifungal strategy does not correlate with mortality in patients with candidemia

  2016cites this paper
• 34th Vicenza Course on AKI and CRRT. Vicenza, June 7-10, 2016: Abstracts

  2016cites this paper
• Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score-derived analysis of a population-based, multicentre prospective cohort.

  2016cites this paper
• [Invasive yeast diseases in solid organ transplant recipients].

  2016cites this paper
• [Update on invasive candidiasis in non-neutropenic critically ill adult patients].

  2016cites this paper
• Prognostic Value of Urine NGAL and Urine IL 18 in Critical Patients at the Admission to an Intensive Care Unit

  2016cites this paper
• Epidemiology and outcome of nosocomial candidemia in elderly patients admitted prevalently in medical wards

  2015cites this paper
• Candidaemia Observed at a University Hospital in Milan (Northern Italy) and Review of Published Studies from 2010 to 2014

  2014influential citation
• Identification and Mechanism of Action of the Plant Defensin NaD1 as a New Member of the Antifungal Drug Arsenal against Candida albicans

  2013cites this paper
• Candida and candidaemia. Susceptibility and epidemiology.

  2013influential citation
• Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients

  2013cites this paper
• Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011.

  2012cites this paper
• Mitochondrial Sorting and Assembly Machinery Subunit Sam37 in Candida albicans: Insight into the Roles of Mitochondria in Fitness, Cell Wall Integrity, and Virulence

  2012cites this paper
• Identification of Candida species isolated from hospital acquired infections cases and hospital indoor environments

  2012cites this paper
• Mortality in patients with early- or late-onset candidaemia

  2012cites this paper
• DESCRIPCION DE LA FLORA CAUSANTE DE CANDIDEMIA EN PACIENTES ADULTOS CRITICAMENTE ENFERMOS Y DETERMINACION DE LOS FACTORES DE RIESGO RELACIONADOS EN LAS UNIDADES DE CUIDADO INTENSIVO DEL HOSPITAL MILITAR CENTRAL EN LOS AÑOS 2006 A 2011

  2012cites this paper
• Opciones terapéuticas para el tratamiento antifúngico en el paciente crítico

  2012cites this paper
• [Antifungal treatment options in the critically ill patient].

  2012cites this paper
• Definitions and Epidemiology of Candida Species not Susceptible to Echinocandins

  2011cites this paper
• [Guidelines for the treatment of Invasive Candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update].

  2011cites this paper
• Aspartic protease inhibitors as potential anti-Candida albicans drugs: impacts on fungal biology, virulence and pathogenesis.

  2011cites this paper
• [The Spanish Society of Paediatric Infectious Diseases (SEIP) recommendations on the diagnosis and management of invasive candidiasis].

  2011cites this paper
• Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

  2011cites this paper
• Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008.

  2011cites this paper
• A Novel Flucytosine-Resistant Yeast Species, Candida pseudoaaseri, Causes Disease in a Cancer Patient

  2011cites this paper
• linical breakpoints for the echinocandins and Candida revisited : Integration of olecular , clinical , and microbiological data to arrive at species-specific nterpretive criteria

  2011cites this paper
• Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia

  2011influential citation
• Antimicrobials in Chemotherapy Strategy

  2011cites this paper
• Epidemiology of invasive candidiasis

  2010cites this paper